These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37998792)

  • 21. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance: a global crisis, problems and solutions.
    Aggarwal R; Mahajan P; Pandiya S; Bajaj A; Verma SK; Yadav P; Kharat AS; Khan AU; Dua M; Johri AK
    Crit Rev Microbiol; 2024 Sep; 50(5):896-921. PubMed ID: 38381581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review.
    Bhowmik P; Modi B; Roy P; Chowdhury A
    Osong Public Health Res Perspect; 2023 Oct; 14(5):333-346. PubMed ID: 37920891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and Carbapenem Susceptibility of Gram-Negative ESKAPE Pathogens in Hospitalized Patients from Three General Hospitals.
    Zhong S; He S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic therapy for pan-drug-resistant infections.
    Ozma MA; Abbasi A; Asgharzadeh M; Pagliano P; Guarino A; Köse Ş; Samadi Kafil H
    Infez Med; 2022; 30(4):525-531. PubMed ID: 36482958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii.
    Morgan CE; Zhang Z; Bonomo RA; Yu EW
    mBio; 2021 Feb; 13(1):e0373221. PubMed ID: 35100868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity.
    Green AB; Chiaraviglio L; Truelson KA; Zulauf KE; Cui M; Zhang Z; Ware MP; Flegel WA; Haspel RL; Yu EW; Kirby JE
    mSphere; 2023 Apr; 8(2):e0067322. PubMed ID: 36853056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
    Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
    PeerJ; 2023; 11():e15007. PubMed ID: 37013147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial Antibiotic Resistance: The Most Critical Pathogens.
    Mancuso G; Midiri A; Gerace E; Biondo C
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
    Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
    ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33920199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections.
    Kanj SS; Bassetti M; Kiratisin P; Rodrigues C; Villegas MV; Yu Y; van Duin D
    Int J Antimicrob Agents; 2022 Sep; 60(3):106633. PubMed ID: 35787918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.